PRIMARY STUDY

Effects of cannabidivarin (CBDV) on brain excitation and inhibition systems in adults with and without Autism Spectrum Disorder (ASD): a single dose trial during magnetic resonance spectroscopy

Key Findings:  This study found that cannabidivarin (CBDV) targets neurotypical and autistic adult brains in mostly the same way, but the individual response to CBDV in the autistic brains was more variable depending on initial glutamate and glutamine levels. This supports further understanding of how CBDV affects the brain, but not necessarily on how it affects the autistic brain.